Silo Wellness Hosts First Wellness Retreat in Jamaica
MONTEGO BAY, Jamaica — On the back of their successful capital raise of CA$4.9 million, Silo Wellness will operate it first wellness retreat in Jamaica.
This expands Silo Wellness psychedelic retreats in both Jamaica and Oregon, USA. Their business plan includes mushroom cultivation in Jamaica as well as a patent-pending nasal spray that has the potential to deliver metered-dosing for psilocybin for mental health ailments.
Jamaica is one of the few countries in the world where psilocybin is legal.
The company also offers non-psychoactive mushroom products via its e-commerce platform www.siloreboot.com. Functional mushrooms include Lion’s Mane, Reiki, Chaga and a host of other species.
There has been tremendous interest and subsequent investment in the scientific benefits of psychedelics and, in particular, psilocybin, one official has suggested.
As an early mover in the psychedelics industry and creators of the patent-pending psilocybin nasal spray in Jamaica, Silo Wellness has been steadily scaling its mushroom and truffle cultivation operations on the island. Silo Wellness aims to help people improve their health and overall wellness, by developing and introducing psychedelics to reduce trauma and increase performance.
Silo Wellness have stated they intend to introduce new, safe, and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal, by conducting ketamine and psilocybin wellness retreats vis-à-vis manufacturing and distributing functional mushrooms.
The retreat is designed to give each guest a transformational experience through the integration of psilocybin, meditation and educational sessions.
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...